Search our Database of Scientific Publications and Authors

I’m looking for a

    23015 results match your criteria Aortic Regurgitation

    1 OF 461

    The Use of Rapid Deployment Valves in Combined Aortic and Mitral Valve Surgery: One-Year Clinical and Echocardiographic Outcomes.
    Innovations (Phila) 2017 May 25. Epub 2017 May 25.
    From the Department of Cardiothoracic Surgery, Ruhr-University Hospital Bergmannsheil, Bochum, Germany.
    Objective: Patients undergoing multiple valve surgery represent a high-risk group who could potentially benefit from a reduction of cross-clamp and cardiopulmonary bypass times because prolonged bypass and cross-clamp times are considered independent risk factors for increased morbidity and mortality after cardiac surgery.

    Methods: Between July 2013 and November 2014, 16 patients underwent rapid deployment aortic valve replacement with the EDWARDS INTUITY valve system in the setting of concomitant mitral disease. Fifteen patients showed mitral regurgitation, whereas one patient had severe mitral stenosis. Read More

    Impact of prosthesis-patient mismatch on short-term outcomes after aortic valve replacement: a retrospective analysis in East China.
    J Cardiothorac Surg 2017 May 25;12(1):42. Epub 2017 May 25.
    Department of Thoracic and Cardiovascular Surgery, First Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
    Background: Prosthesis-patient mismatch (PPM) may affect the clinical outcomes of patients undergoing aortic valve replacement (AVR). We aimed to determine the incidence of PPM, its effect on short-term mortality, and the factors contributing to PPM in China.

    Methods: We retrospectively examined all consecutive patients with isolated or concomitant AVR at our hospital between January 1, 2013 and December 31, 2015. Read More

    A New Sign of Severe Aortic Regurgitation Detected Through Airflow Analysis in Mechanical Ventilation.
    J Heart Valve Dis 2017 Jan;26(1):121
    Coronary Care Unit. Hospital Virgen Macarena. Sevilla, Spain.
    A 72-year-old female with a previous history of aortic valve replacement by biological prosthesis was admitted with progressive heart failure. The clinical course was unfavorable, requiring inotropic support and invasive mechanical ventilation. Auto-triggering of the ventilator from cardiac origin has been previously described, and explained as a consequence of hyperdynamic circulation. Read More

    Transfemoral Valve-In-Valve in a Degenerated Small Aortic Bioprosthesis: Five-Year Follow Up.
    J Heart Valve Dis 2017 Jan;26(1):118-120
    Division of Cardiology, Città della Salute e della Scienza 'Molinette', Turin, Italy.
    A small-sized bioprosthesis can limit transcatheter valve-in-valve (V-in-V) implantations. The case is reported of a 91-year-old woman who had successfully undergone a V-in-V procedure with a 26 mm CoreValve in a previously implanted Mitroflow 19 mm valve. At the five-year follow up the prosthesis showed good echocardiographic function and the patient was alive and free from major symptoms. Read More

    Transcatheter Valve-in-Valve Implantation: Failing Tricuspid Bioprosthesis in a Patient with Ebstein’s Anomaly.
    J Heart Valve Dis 2017 Jan;26(1):114-117
    Division of Cardiovascular Diseases, Montefiore Medical Center/Albert Einstein College of Medicine, New York, NY, USA.
    Transcatheter valve-in-valve (VIV) implantation has been recently proposed as an alternative to surgical reoperative aortic valve replacement in patients with a failing aortic bioprosthesis. Experience with transcatheter VIV implantation at other valve positions is very limited. Herein is reported the case of an 18-year-old man with Ebstein's anomaly and severe tricuspid valve (TV) regurgitation status after bioprosthetic valve replacement, who developed new dyspnea on exertion three years after the initial valve replacement. Read More

    Redo Tricuspid Valve Repair with Leaflet Augmentation Using the Left Atrial Wall.
    J Heart Valve Dis 2017 Jan;26(1):111-113
    Department of Cardiovascular Surgery, Juntendo University, Tokyo, Japan.
    The case is reported of a 79-year-old female who received a patch augmentation of the tricuspid anterior and septal leaflets with a resected left atrial wall to address recurrent tricuspid regurgitation, including tricuspid valve tethering. The patient was admitted to the authors' hospital for chronic heart failure with paravalvular leakage after aortic valve replacement and recurrent severe tricuspid regurgitation. She had undergone two previous cardiac surgeries. Read More

    Granulomatosis with Polyangiitis Presenting with Acute Aortic and Mitral Regurgitation: Case Report and Big-Data Analysis.
    J Heart Valve Dis 2017 Jan;26(1):103-106
    Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA. Electronic correspondence:
    Granulomatosis with polyangiitis (GPA) is a rare vasculitis that can have multisystem involvement, though cardiac involvement is very rare. The case is described of a 53-year-old woman who presented with acute aortic and mitral valve regurgitation requiring surgical intervention. Pathology from the excised aortic valve showed geographic necrosis concerning for GPA. Read More

    Aortic Root Surgery in Marfan Syndrome: Medium-Term Outcome in a Single-Center Experience.
    J Heart Valve Dis 2017 Jan;26(1):45-53
    Division of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA.
    Background: The study aim was to analyze the authors' experience with aortic root surgery in Marfan syndrome (MFS), and to expand the surgical outcome data of patients meeting the Ghent criteria (Marfan registry).

    Methods: Analyses were performed of data acquired from MFS patients (who met the Ghent criteria), including an aortic root surgery and Kaplan-Meier survival.

    Results: Between April 2004 and February 2012, a total of 59 MFS patients (mean age at surgery 36 ± 13 years) underwent 67 operations for aortic root aneurysm (n = 52), aortic valve (AV) regurgitation (n = 15), acute aortic dissection (n = 2), and/or mitral valve (MV) regurgitation resulting from MV prolapse (n = 7). Read More

    Assessment of Contributors of Aortopathy and Subclinical Left Ventricular Dysfunction in Normally Functioning Bicuspid Aortic Valves.
    J Heart Valve Dis 2017 Jan;26(1):37-44
    Izmir Katip Çelebi University, Atatürk Training and Research Hospital, Department of Cardiology, Izmir, Turkey.
    Background: Left ventricular (LV) function and the dimensions of aortic valves from normally functioning bicuspid aortic valve (BAV) patients were compared with those of healthy control patients. A comparison between patients with antero-posterior BAV (BAV-AP) or right-left BAV (BAV-RL) was also performed, and the determinants of aortopathy and LV function were investigated.

    Methods: Sixty-eight patients with aortic velocities <2 m/s and trivial or mild aortic regurgitation were included in the study. Read More

    Acute Aortic Regurgitation in the Current Era of Percutaneous Treatment: Pathophysiology and Hemodynamics.
    J Heart Valve Dis 2017 Jan;26(1):22-31
    Gulhane Military Medical Academy, Department of Cardiology, Ankara, Turkey.
    Aortic regurgitation (AR) is characterized by the backflow of blood from the aorta to the left ventricle. Acute AR typically causes severe pulmonary edema and hypotension, and is a surgical emergency. In chronic AR, however, compensatory mechanisms can clinically compensate for years, with normal left ventricular function and no symptoms. Read More

    Procedural Techniques for the Management of Severe Transvalvular and Paravalvular Aortic Regurgitation During TAVR.
    J Heart Valve Dis 2017 Jan;26(1):18-21
    Cardiovascular Division, Department of Medicine, University of Miami Miller School of Medicine and the Elaine and Sydney Sussman Cardiac Catheterization Laboratory, University of Miami Hospital, Miami, USA.
    Aortic regurgitation (AR) after transcatheter aortic valve replacement (TAVR) is associated with an increased risk of mortality. In severe cases, abrupt hemodynamic changes may occur with a sudden increase in left ventricular end-diastolic pressure that results in frank pulmonary edema, hypoxia, and cardiogenic shock. Here, the case is reported of a patient who developed severe AR immediately after valve deployment that led to severe hemodynamic compromise. Read More

    Perventricular device closure of doubly committed sub-arterial ventricular septal defects via a left infra-axillary approach.
    J Card Surg 2017 May 24. Epub 2017 May 24.
    Department of Cardiovascular Surgery and Ultrasound, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China.
    Background: This study sought to evaluate the feasibility, safety, and efficacy of perventricular device closure of a doubly committed sub-arterial ventricular septal defect (dcVSD) through a left infra-axillary approach.

    Method: Forty-five patients, with a dcVSD of less than 8 mm in diameter, were enrolled in this study. The pericardium was exposed and opened through a left infra-axillary mini-incision. Read More

    Failed TAVI in TAVI Implantation: TAVI Dislocation Followed by Ensuing Surgical Graft Resection.
    Case Rep Cardiol 2017 30;2017:5086586. Epub 2017 Apr 30.
    2nd Surgical Clinic of Cardiovascular Surgery, General Teaching Hospital, Prague, Czech Republic.
    We are presenting a case report of failed valve-in-valve treatment of severe aortic stenosis. A control ultrasonography after TAVI implantation revealed a severe aortic regurgitation of the graft which was subsequently unresolved with postimplantation dilatation. Second TAVI was implanted with cranial dislocation to the aortic root. Read More

    Standard imaging techniques in transcatheter aortic valve replacement.
    J Thorac Dis 2017 Apr;9(Suppl 4):S289-S298
    Department of Cardiothoracic Surgery, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY, USA.
    Transcatheter aortic valve replacement (TAVR) has become a widely accepted therapeutic option for patients with severe, symptomatic aortic stenosis at intermediate, high, or extreme risk for conventional surgery as determined through a heart team approach. Two valve prostheses are currently available and the Food and Drug Administration (FDA) approved in the United States for TAVR: the self-expandable Medtronic CoreValve (Medtronic, Inc., Minneapolis, MN, USA) and the balloon-expandable Edwards Sapien Valve (Edwards Lifesciences, Irvine CA, USA). Read More

    Transcatheter aortic valve implantation in patients on corticosteroid therapy.
    Heart Vessels 2017 May 23. Epub 2017 May 23.
    Department of Cardiology, Sakakibara Heart Institute, 3-16-1 Asahi-cho, Fuchu, Tokyo, 183-0003, Japan.
    Transcatheter aortic valve implantation (TAVI) is recommended for patients who are inoperable or at high risk for surgical aortic valve replacement (SAVR). Corticosteroid therapy is considered to be a risk factor for SAVR, but there is a paucity of information about TAVI in patients taking corticosteroids. The aim of this study is to elucidate the outcome of TAVI in patients on chronic corticosteroid therapy, compared with SAVR. Read More

    Predictors of Paravalvular Regurgitation After Implantation of the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve (from the REPRISE II Trial Extended Cohort).
    Am J Cardiol 2017 Apr 27. Epub 2017 Apr 27.
    Boston Scientific Corporation, Marlborough, Massachusetts.
    Paravalvular leak (PVL) after transcatheter aortic valve replacement is associated with worse long-term outcomes. The Lotus Valve incorporates an innovative Adaptive Seal designed to minimize PVL. This analysis evaluated the incidence and predictors of PVL after implantation of the Lotus transcatheter aortic valve. Read More

    The emerging role of Cardiovascular Magnetic Resonance in the evaluation of hypertensive heart disease.
    BMC Cardiovasc Disord 2017 May 23;17(1):132. Epub 2017 May 23.
    Asklipiion Voulas, Athens, Greece.
    Background: Arterial hypertension is the commonest cause of cardiovascular death. It may lead to hypertensive heart disease (HHD), including heart failure (HF), ischemic heart disease (IHD) and left ventricular hypertrophy (LVH).

    Main Body: According to the 2007 ESH/ESC guidelines, the recommended imaging technique is echocardiography (echo), when a more sensitive detection of LVH than that provided by ECG, is needed. Read More

    Transcatheter aortic valve implantation for recurrent Valsalva sinus re-dissection and severe aortic regurgitation shortly after surgery for type-A aortic dissection.
    Interact Cardiovasc Thorac Surg 2017 May 23. Epub 2017 May 23.
    Cardiac Surgery, Cardiocentro Ticino, Lugano, Switzerland.
    Delayed aortic regurgitation following Valsalva sinus re-dissection is a well-known complication that can occur at any time after surgery for type-A aortic dissection without root replacement. We describe a case of acute type-A dissection in an 81-year-old lady successfully treated with aortic valve resuspension and ascending aorta replacement with a 28-mm vascular graft. A month later, the patient was readmitted for worsening heart failure and a transthoracic echocardiogram showed severe aortic regurgitation secondary to non-coronary Valsalva sinus re-dissection and non-coronary aortic valve leaflet prolapse also confirmed at computed tomography scan. Read More

    Concomitant repair for mild aortic insufficiency and continuous-flow left ventricular assist devices.
    Eur J Cardiothorac Surg 2017 May 23. Epub 2017 May 23.
    Division of Cardiac, Thoracic and Vascular Surgery, Department of Surgery, Columbia University Medical Center, New York, NY, USA.
    Objectives: Aortic insufficiency (AI) after continuous-flow left ventricular assist device (CF-LVAD) implantation has become a highly relevant subject. However, management of pre-existing mild AI is unknown. We examined the fate of pre-existing mild AI during CF-LVAD support. Read More

    Bicuspid Aortic Valve: An Unusual Cause of Aneurysm of Left Coronary Sinus of Valsalva.
    Iran J Med Sci 2017 May;42(3):310-313
    Department of Neonatology and Pediatric Medicine, PGIMER, Dr. RML Hospital, New Delhi, India.
    Bicuspid aortic valve is traditionally considered an innocuous congenital anomaly. Due to a better and widespread availability of non-invasive imaging techniques, it has come to the fore that 30% of these cases develop complications, viz., valve abnormality (aortic regurgitation and stenosis), and aneurysm of aortic root and ascending aorta. Read More

    Prevalence and Complications of Bicuspid Aortic Valve in Chinese According to Echocardiographic Database.
    Am J Cardiol 2017 Apr 27. Epub 2017 Apr 27.
    Department of Cardiology, West China Hospital, Sichuan University, Chengdu, People's Republic of China. Electronic address:
    As transcatheter aortic valve replacement has become an alternative treatment for patients at high risk for surgical aortic valve replacement, bicuspid aortic valve (BAV) draws our attention again. The reported frequency of BAV was 0.5% to 2% in western population. Read More

    The flaws in the detail of an observational study on transcatheter aortic valve implantation versus surgical aortic valve replacement in intermediate-risks patients.
    Eur J Cardiothorac Surg 2017 Jun;51(6):1031-1035
    Department of Cardiac Surgery, IRCCS Policlinico S. Donato, Milan, Italy.
    The PARTNER group recently published a comparison between the latest generation SAPIEN 3 transcatheter aortic valve implantation (TAVI) system (Edwards Lifesciences, Irvine, CA, USA) and surgical aortic valve replacement (SAVR) in intermediate-risk patients, apparently demonstrating superiority of the TAVI and suggesting that TAVI might be the preferred treatment method in this risk class of patients. Nonetheless, assessment of the non-randomized methodology used in this comparison reveals challenges that should be addressed in order to elucidate the validity of the results. The study by Thourani and colleagues showed several major methodological concerns: suboptimal methods in propensity score analysis with evident misspecification of the propensity scores (PS; no adjustment for the most significantly different covariates: left ventricular ejection fraction, moderate-severe mitral regurgitation and associated procedures); use of PS quintiles rather than matching; inference on not-adjusted Kaplan-Meier curves, although the authors correctly claimed for the need of balancing score adjusting for confounding factors in order to have unbiased estimates of the treatment effect; evidence of poor fit; lack of data on valve-related death. Read More

    Low pacemaker incidence with continuous-sutured valves: a retrospective analysis.
    Asian Cardiovasc Thorac Ann 2017 Jan 1:218492317712309. Epub 2017 Jan 1.
    Department of Cardiovascular Surgery, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.
    Background Permanent pacemaker implantation after surgical aortic valve replacement depends on patient selection and risk factors for conduction disorders. We aimed to identify risk criteria and obtain a selected group comparable to patients assigned to transcatheter aortic valve implantation. Methods Isolated sutured aortic valve replacements in 994 patients treated from 2007 to 2015 were reviewed. Read More

    Pulmonary Flow as an Improved Method for Determining Cardiac Output in Mice after Myocardial Infarction.
    J Am Soc Echocardiogr 2017 Jun;30(6):612-623.e1
    Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada. Electronic address:
    Background: Echocardiography is a valuable noninvasive technique to estimate cardiac output (CO) from the left ventricle (LV) not only in clinical practice but also in small-animal experiments. CO is used to grade cardiac function and is especially important when investigating cardiac injury (e.g. Read More

    Testing of a novel percutaneous temporary aortic valve in a rabbit model of acute severe aortic regurgitation: an experimental study.
    Int J Artif Organs 2017 May 18. Epub 2017 May 18.
    HOCOR Cardiovascular Technologies, Honolulu - Hawaii.
    Purpose: Device management of hemodynamic instability due to acute aortic regurgitation is not available. A novel, catheter-based, temporary aortic valve (TAV) has been in development. Early prototypes (balloon-based TAV) have undergone proof-of-concept studies in mathematical, bench and animal models. Read More

    Long-term durability of preserved aortic root after repair of acute type A aortic dissection.
    Gen Thorac Cardiovasc Surg 2017 May 18. Epub 2017 May 18.
    Department of Thoracic and Cardiovascular Surgery, Saga University Hospital, Saga, Japan.
    Background: Optimal management of aortic root in type A aortic dissection (AAD) is controversial. To determine the most appropriate strategy, we studied the late outcomes after conservative repair of aortic root.

    Methods: 234 AAD patients (mean age 68 ± 12 years) underwent surgical repair using supracommissural replacement (SCR) for aortic root reconstruction from 1989 to 2014. Read More

    Safety and Efficacy of Transcatheter Aortic Valve Replacement in the Treatment of Pure Aortic Regurgitation in Native Valves and Failing Surgical Bioprostheses: Results From an International Registry Study.
    JACC Cardiovasc Interv 2017 May;10(10):1048-1056
    Rigshospitalet University Hospital, Copenhagen, Denmark.
    Objectives: The aim of this study was to evaluate the use of transcatheter heart valves (THV) for the treatment of noncalcific pure native aortic valve regurgitation (NAVR) and failing bioprosthetic surgical heart valves (SHVs) with pure severe aortic regurgitation (AR).

    Background: Limited data are available about the "off-label" use of transcatheter aortic valve replacement (TAVR) to treat pure severe AR.

    Methods: The study population consisted of patients with pure severe AR treated by TAVR at 18 different centers. Read More

    1-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical Bioprostheses.
    JACC Cardiovasc Interv 2017 May;10(10):1034-1044
    Department of Internal Medicine, Cardiovascular Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
    Objectives: This study evaluated the safety and effectiveness of self-expanding transcatheter aortic valve replacement (TAVR) in patients with surgical valve failure (SVF).

    Background: Self-expanding TAVR is superior to medical therapy for patients with severe native aortic valve stenosis at increased surgical risk.

    Methods: The CoreValve U. Read More

    Role of mitral valve repair in active infective endocarditis: long term results.
    J Cardiothorac Surg 2017 May 18;12(1):29. Epub 2017 May 18.
    Cardiochirurgia, AOU Careggi Firenze, Florence, Italy.
    Background: Although mitral valve repair is at present the technique of choice in mitral regurgitation (MR) due to degenerative valve disease, long term results in patients with active mitral infective endocarditis (IE) are still under evaluation.

    Methods: In the study were included 34 consecutive patients (22 males; mean age, 60 years; range 32-84 years) referred to our institution between January 1, 2005 to December 31, 2011 who were treated with valve repair for mitral valve (MV) active infective endocarditis. Eighteen patients underwent isolated MV repair. Read More

    Gerbode defect and multivalvular dysfunction: Complex complications in adult congenital heart disease.
    Echocardiography 2017 May 18. Epub 2017 May 18.
    Cardiology Department, Leiria Hospital Center, Leiria, Portugal.
    We report a clinical case of a 40-year-old male with surgically corrected congenital heart disease (CHD) 10 years earlier: closure of ostium primum, mitral annuloplasty, and aortic valve and root surgery. The patient was admitted with acute heart failure. Transesophageal echocardiography (TEE) revealed a dysmorphic and severely incompetent aortic valve, a partial tear of the mitral valve cleft repair and annuloplasty ring dehiscence. Read More

    Late Presentation of Aortic Aneurysm and Dissection Following Cardiac Catheterization.
    Cardiol Res 2017 Apr 3;8(2):68-72. Epub 2017 May 3.
    Division of Cardiology, University of South Alabama, Mobile, AL, USA.
    We report a 63-year-old female with hypertension, hyperlipidemia, and prior pacemaker insertion for atrial fibrillation with symptomatic bradycardia, who was admitted with substernal chest pressure and diaphoresis. Her electrocardiogram revealed atrial fibrillation with demand ventricular pacing and her cardiac biomarkers were negative for acute coronary syndrome. Echocardiogram revealed normal left ventricular systolic function and normal aortic root diameter. Read More

    A retrospective analysis of mitral valve pathology in the setting of bicuspid aortic valves.
    Echo Res Pract 2017 May 17. Epub 2017 May 17.
    A van Rensburg, Department of Medicine, Division of Cardiology, Tygerberg Academic Hospital, Cape Town, South Africa.
    The therapeutic implications of bicuspid aortic valve associations have come under scrutiny in the transcatheter aortic valve implantation era. We evaluate the spectrum of mitral valve disease in patients with bicuspid aortic valves to determine the need for closer echocardiographic scrutiny/follow-up of the mitral valve. A retrospective analysis of echocardiograms done at a referral hospital over five years was conducted in patients with bicuspid aortic valves with special attention to congenital abnormalities of the mitral valve. Read More

    United Kingdom: coronary and structural heart interventions from 2010 to 2015.
    EuroIntervention 2017 05;13(Z):Z83-Z88
    Queen Elizabeth Hospital, University Hospital Birmingham NHS Foundation Trust, Edgbaston, Birmingham, United Kingdom.
    In the United Kingdom, a clinical data set is completed for every patient undergoing coronary intervention and certain structural interventions, and sent to central servers in the National Institute for Cardiovascular Outcomes Research (NICOR) on behalf of the British Cardiovascular Intervention Society (BCIS). These data are linked to the national mortality register. In addition, data are obtained about the structure of healthcare provision using an annual survey. Read More

    A cohort study reveals myocarditis to be a rare and life-threatening presentation of large vessel vasculitis.
    Semin Arthritis Rheum 2017 Apr 4. Epub 2017 Apr 4.
    Rheumatology Department, Imperial College Healthcare NHS Trust and Imperial College London, Hammersmith Hospital, London, UK.
    Background: The predominant forms of adult large vessel vasculitis (LVV) are giant cell arteritis (GCA) and Takayasu arteritis (TA). Cardiac involvement in LVV is a cause of morbidity and mortality, particularly in TA. Cardiac failure is most commonly secondary to uncontrolled arterial hypertension or myocardial ischaemia. Read More

    Feasibility and safety of transfemoral sheathless portico aortic valve implantation: Preliminary results in a single center experience.
    Catheter Cardiovasc Interv 2017 May 13. Epub 2017 May 13.
    Heart Valve Clinic, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
    Background: Feasibility of transfemoral (TF) transcathteter aortic valve replacement (TAVR) is limited by the smallest diameter, the calcification and tortuosity of the iliofemoral access vessels. The use of the Portico system without delivery sheath results in significantly lower profile delivery system compared to standard technique. We herein report our single center experience, feasibility and safety of such an approach. Read More

    Tricuspid annuloplasty versus a conservative approach in patients with functional tricuspid regurgitation undergoing left-sided heart valve surgery: A study-level meta-analysis.
    Int J Cardiol 2017 May 5. Epub 2017 May 5.
    Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy; Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy. Electronic address:
    Background: Tricuspid valve (TV) repair at the time of left-sided valve surgery is indicated in patients with either severe functional tricuspid regurgitation (TR) or mild-to-moderate TR with coexistent tricuspid annular dilation or right heart failure. We assessed the benefits of a concomitant TV repair strategy during left-sided surgical valve interventions, focusing on mortality and echocardiographic TR-related outcomes.

    Methods: A meta-analysis was performed of studies reporting outcomes of patients who underwent left-sided (mitral and/or aortic) valve surgery with or without concomitant TV repair. Read More

    Which technique of cusp repair is durable in reimplantation procedure?†.
    Eur J Cardiothorac Surg 2017 May 11. Epub 2017 May 11.
    Department of Cardiovascular Surgery, Kobe University Hospital, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Japan.
    Objectives: We aimed to ascertain the durability of cusp repair techniques used in reimplantation procedures.

    Methods: Between 2000 and 2015, 249 patients (mean age, 49 ± 17 years) with aortic insufficiency underwent the reimplantation procedure. The pathology was acute aortic dissection in 24 and non-dissection in 225 patients. Read More

    [Rupture of an Aneurysm of the Right Sinus of Valsalva Into the Pericardium;Report of a Case].
    Kyobu Geka 2017 May;70(5):385-388
    Department of Cardiothoracic Surgery, Jichi Medical University, Tochigi, Japan.
    A sinus of Valsalva aneurysm is an uncommon cardiac anomaly. The aneurysm usually ruptures into the cardiac cavity, and rupture into the pericardial cavity is unusual. A 69-year-old man was admitted to our hospital after collapse due to cardiac tamponade. Read More

    [Surgical Treatment for Anomalous Aortic Origin of Coronary Arteries].
    Kyobu Geka 2017 May;70(5):342-347
    Department of Cardiovascular Surgery, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan.
    Anomalous aortic origin of coronary arteries is rare. We report 3 cases of surgical treatment for anomalous aortic origin of coronary arteries. Case 1 was a 38-year-old man who was saved by the use of an automated external defibrillator from cardiopulmonary arrest while exercising. Read More

    Contemporary transcatheter aortic valve replacement with third-generation balloon-expandable versus self-expanding devices.
    J Interv Cardiol 2017 May 11. Epub 2017 May 11.
    Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia.
    Objectives: To evaluate balloon-expandable and self-expanding third-generation transcatheter aortic valve replacement (TAVR) devices according to patient selection criteria and outcomes.

    Background: Two competing third-generation TAVR technologies are currently commercially available in the US. There are no published head-to-head comparisons of the relative performance of these two devices. Read More

    Rapid-deployment aortic valve replacement versus standard bioprosthesis implantation.
    J Card Surg 2017 May 11. Epub 2017 May 11.
    University Hospital of Lausanne, Cardiovascular Research Unit, Lausanne, Switzerland.
    Objective: To compare the outcome and the 1-year hemodynamic results of the rapid-deployment Intuity valve versus the Perimount Magna bioprosthesis in matched populations.

    Methods: Between March 2014 and May 2015, 32 patients underwent aortic valve replacement with the Intuity valve (Intuity-group). These patients were compared to a matched population of Perimount valves implanted during the same period of time (Perimount-group). Read More

    Does aortic valve repair in valve-sparing aortic root reconstruction compromise the longevity of the procedure?
    Clinics (Sao Paulo) 2017 Apr;72(4):207-212
    Cirurgia Cardiovascular, Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR.
    Objectives:: The effect of performing aortic valve repair in combination with valve-sparing operation on the length of time for which patients are free from reoperation is unclear. The objective of this study was to determine if the performance of aortic valve repair during valve-sparing operation modified the freedom from reoperation time.

    Methods:: From January 2003 to July 2014, 78 patients with a mean age of 49±15 years underwent valve-sparing operation. Read More

    Contemporary natural history of bicuspid aortic valve disease: a systematic review.
    Heart 2017 May 10. Epub 2017 May 10.
    Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.
    We performed a systematic review of the current state of the literature regarding the natural history and outcomes of bicuspid aortic valve (BAV). PubMed and the reference lists of the included articles were searched for relevant studies reporting on longitudinal follow-up of BAV cohorts (mean follow-up ≥2 years). Studies limited to patients undergoing surgical interventions were excluded. Read More

    Long-Term Cardiac Morbidity and Mortality in Patients With Aortic Valve Disease Following Liver Transplantation: A Case Matching Study.
    Semin Cardiothorac Vasc Anesth 2017 May 1:1089253217708034. Epub 2017 May 1.
    1 Department of Anesthesiology, Ochsner Medical Center, New Orleans, LA, USA.
    Introduction: This retrospective study examined the role of aortic valve (AV) disease in patients who underwent orthotopic liver transplantation (OLT) to determine the incidence of postoperative cardiac morbidity and mortality when compared with a matched control group without AV disease.

    Methods: Patients were included in the AV group if diagnosed with aortic stenosis (AS) or aortic regurgitation or had received AV replacement prior to OLT. The AV group (n = 53) was matched to a control group (n = 212) with the following preoperative variables: type of organ transplanted, age, gender, race, body mass index, MELD, redo-transplantation, preoperative renal replacement therapy, nonalcoholic steatohepatitis, viral hepatitis, diabetes, and coronary artery disease. Read More

    Validation of 3D-reconstructed computed tomography images using OsiriX® software for pre-transcatheter aortic valve implantation aortic annulus sizing.
    Interact Cardiovasc Thorac Surg 2017 May 8. Epub 2017 May 8.
    Department of Cardiac and Vascular Surgery, Inselspital University Hospital Bern, University of Bern, Bern, Switzerland.
    Objectives: We report validation of OsiriX -an image processing freeware-to measure multi-slice computed tomography-derived annulus diameters for preprocedural transcatheter aortic valve implantation planning.

    Methods: A total of 137 patients (82 ± 6.5 years, 42. Read More

    1 OF 461